Investor Relations


Micrus Endovascular is a medical device company formed in June 1996 with its corporate headquarters in San Jose, Calif. Micrus develops, manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Micrus products are used by interventional neuroradiologists and neurosurgeons primarily to treat cerebral aneurysms responsible for hemorrhagic stroke, a significant cause of death worldwide. The Micrus product line enables physicians to gain access to the brain in a minimally invasive manner through the vessels of the circulatory system. Micrus? proprietary, three-dimensional microcoils are unique in that they automatically deploy within the aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes. Micrus also sells accessory devices and products used in conjunction with its microcoils.

 Cerecyte Coils in the Treatment of Intracranial Aneurysms: A Preliminary Clinical
Study

 MSN Money Video clip of Wachovia Conference Presentation (1/30/07)

Symbol

MEND

Index

NASDAQ

Last Trade

4:00 PM ET
Jul 2, 2009

Price

$9.24

Change

+ 0.02

Volume

81,500

Day High

$9.66

Day Low

$8.90




Jun 3, 2009
Micrus Endovascular to Present at June Investment Conferences

May 7, 2009
Micrus Endovascular Reports Fourth Quarter Diluted EPS of $0.04

>> All News Releases